Coordinated Selloff Across Three Assets

$LAB, $BCH, and $AVAX are all trading lower in the Asia session with synchronized pressure across the board. $LAB has fallen 13.09% over 24 hours to $9.51, while $BCH sits at $213 (down 12.24%) and $AVAX trades at $6.68 (off 10.46%). This coordinated weakness suggests macro headwinds rather than asset-specific catalysts—likely correlation with broader risk sentiment.

Volume is substantial: $LAB commanded $112M, $BCH $266M, and $AVAX $456M in 24-hour turnover. The depth of selling at these levels indicates institutional and retail positioning adjusting simultaneously across the altcoin complex.

Support Levels Under Pressure

$AVAX's breakdown through $7 represents a critical technical failure. The $6.68 level now marks the session low, with next structural support sitting around $6.40–$6.50. If Asia session traders fail to stabilize price above $6.80, further liquidation cascades are plausible given the velocity of the move.

$BCH's $213 mark is significant—it represents the swing low from the prior week. Breakdown below this level opens a path to $200 psychological support. The $266M volume spike confirms this is not light, algorithmic selling; real capital is exiting positions.

$LAB, trading at $9.51, has shed its $11 resistance and is now testing $9.50 as a floor. The $112M volume is lighter than peers, suggesting less institutional participation but potentially faster repricing risk if capitulation accelerates.

Asia Session Dynamics and Overnight Positioning

The Asia session typically sets overnight levels for London and New York sessions. If this selling persists through the next 8–12 hours, it establishes lower reference points that inbound sessions will be forced to respect. Liquidation cascades in Asia often trigger stop-hunt mechanics as positions unwind across time zones.

Funding rates on perpetual futures across these assets are worth monitoring. If shorts are piling in aggressively, a squeeze is structurally possible once Asia exhausts the initial wave of sellers. Conversely, if longs are capitulating, further downside pressure becomes the base case.

The coordinated nature of the decline—three uncorrelated assets all posting 10–13% losses—signals macro beta trade rather than fundamental deterioration in any single protocol or project.

Key Takeaways

  • $LAB ($9.51, -13.09%), $BCH ($213, -12.24%), and $AVAX ($6.68, -10.46%) all breach key technical support in synchronized selloff across $834M combined volume
  • $AVAX's sub-$7 breakdown and $BCH's sub-$213 close represent structural failures likely to draw inbound liquidity sellers
  • Asia session is establishing overnight levels; subsequent sessions will inherit this damage unless stabilization occurs in next 8–12 hours
  • Liquidation risk remains acute; funding rates and perpetual positioning will determine bounce elasticity